company background image
530549 logo

Shilpa Medicare BSE:530549 Stock Report

Last Price

₹461.35

Market Cap

₹40.0b

7D

1.2%

1Y

102.0%

Updated

28 Mar, 2024

Data

Company Financials

Shilpa Medicare Limited

BSE:530549 Stock Report

Market Cap: ₹40.0b

530549 Stock Overview

Shilpa Medicare Limited, together with its subsidiaries, engages in the manufacturing and selling active pharmaceutical ingredients (APIs), intermediates, and formulations in India, the United States, Europe, and internationally.

530549 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Shilpa Medicare Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shilpa Medicare
Historical stock prices
Current Share Price₹461.35
52 Week High₹468.65
52 Week Low₹225.05
Beta0.78
1 Month Change7.05%
3 Month Change39.63%
1 Year Change101.99%
3 Year Change30.14%
5 Year Change38.23%
Change since IPO20,253.68%

Recent News & Updates

Recent updates

Shareholder Returns

530549IN PharmaceuticalsIN Market
7D1.2%2.4%1.8%
1Y102.0%65.8%48.6%

Return vs Industry: 530549 exceeded the Indian Pharmaceuticals industry which returned 63.9% over the past year.

Return vs Market: 530549 exceeded the Indian Market which returned 47.3% over the past year.

Price Volatility

Is 530549's price volatile compared to industry and market?
530549 volatility
530549 Average Weekly Movement7.9%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.6%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.0%

Stable Share Price: 530549's share price has been volatile over the past 3 months.

Volatility Over Time: 530549's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19871,179Vishnukanth Bhutadahttps://www.vbshilpa.com

Shilpa Medicare Limited, together with its subsidiaries, engages in the manufacturing and selling active pharmaceutical ingredients (APIs), intermediates, and formulations in India, the United States, Europe, and internationally. It’s primary oncology and non-oncology APIs include capecitabine, gemcitabine hydrochloride, pemetrexed, axitinib, erlotinib hydrochloride, and irinotecan hydrochloride, as well as ambroxol, tranexmic acid, and ursodeoxycholic acid; and new drug delivery systems, peptides/biotech products, and specialty chemicals, etc. The company provides contract manufacturing of various dosage forms, such as tablets, capsules, liquid injections, lyophilized injectables, and sterile dry powder injectables. In addition, It is involved in the wind power generation activities.

Shilpa Medicare Limited Fundamentals Summary

How do Shilpa Medicare's earnings and revenue compare to its market cap?
530549 fundamental statistics
Market cap₹40.05b
Earnings (TTM)-₹6.71m
Revenue (TTM)₹11.25b

3.6x

P/S Ratio

-5,971x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
530549 income statement (TTM)
Revenue₹11.25b
Cost of Revenue₹4.44b
Gross Profit₹6.81b
Other Expenses₹6.81b
Earnings-₹6.71m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.077
Gross Margin60.53%
Net Profit Margin-0.06%
Debt/Equity Ratio48.8%

How did 530549 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.